Ryo Nagashio - Publications

Epigenomic profiling of neuroendocrine lung cancers identifies a classical-neuroendocrine ASCL1/NKX2-1 subtype and a SOX11-associated differentiation axis linked to reduced immunogenicity.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: April 06, 2026

Insight Into the Significance of CD8+ Tumor-Infiltrating Lymphocytes in Lung Adenocarcinoma.

Journal: Thoracic cancer

Published: April 16, 2025

Insight into the significance of Foxp3 + tumor-infiltrating lymphocytes in squamous cell lung cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: October 28, 2023

Insight into the significance of CD8+ tumor-infiltrating lymphocytes in squamous cell lung cancer.

Journal: Thoracic cancer

Published: October 28, 2023

DJ-1 Expression Might Serve as a Biologic Marker in Patients with Bladder Cancer.

Journal: Cancers

Published: April 13, 2022

Prognostic significance of galectin-3 expression in patients with resected NSCLC treated with platinum-based adjuvant chemotherapy.

Journal: Thoracic cancer

Published: February 12, 2021

Prognostic significance of NAP1L1 expression in patients with early lung adenocarcinoma.

Journal: Biomedical research (Tokyo, Japan)

Published: June 12, 2020

Expression of CA2 and CA9 carbonic anhydrases in ulcerative colitis and ulcerative colitis-associated colorectal cancer.

Journal: Pathology international

Published: March 01, 2020

TRAP1 is a predictive biomarker of platinum-based adjuvant chemotherapy benefits in patients with resected lung adenocarcinoma.

Journal: Biomedical research (Tokyo, Japan)

Published: February 25, 2020

Prognostic significance of IMMT expression in surgically-resected lung adenocarcinoma.

Journal: Thoracic cancer

Published: July 16, 2019

Clinicopathological and prognostic significance of nuclear UGDH localization in lung adenocarcinoma.

Journal: Biomedical research (Tokyo, Japan)

Published: February 22, 2019

TROY expression is associated with pathological stage and poor prognosis in patients treated with radical cystectomy.

Journal: Cancer biomarkers : section A of Disease markers

Published: November 27, 2018